A real world experience with fingolimod in active RRMS patients naïve to second-line agents: a 2 years, intention-to-treat, observational, single center study
暂无分享,去创建一个
G. Comi | A. Ghezzi | M. Zaffaroni | G. Minonzio | D. Baroncini | P. Annovazzi | A. Bianchi | P. Annovazzi | S. Baldini | D. Baroncini | P. O. Annovazzi | G. Minonzio